Kämpe Mary, Janson Christer, Stålenheim Gunnemar, Stolt Ingrid, Carlson Marie
Department of Medical Sciences, Respiratory Medicine and Allergology, University Hospital, Uppsala, Sweden.
Clin Respir J. 2010 Jan;4(1):37-44. doi: 10.1111/j.1752-699X.2009.00140.x.
Seasonal allergy is an interesting model to study the pathophysiological mechanisms involved in allergic inflammation. However, experimental allergen exposure is easier to perform and standardise. The primary aim of this study was to compare the inflammatory responses to high-dose bronchial challenge and natural exposure during birch pollen season. The second aim was to compare the responses of patients with allergic rhinitis and allergic asthma, respectively to both types of allergen exposure.
Fifteen birch pollen-allergic patients (seven with asthma and eight with rhinitis) and five healthy individuals were studied during pollen season and after challenge with birch allergen. Symptoms, medication and peak expiratory flow rate (PEFR) were recorded, and blood samples, spirometry and induced sputum were analysed during season and after challenge.
Patients with allergic asthma demonstrated a greater bronchial responsiveness to bronchial provocation with birch allergen than patients with rhinitis (P = 0.04) whereas no difference was found regarding nasal challenge. No significant association was found between the level of responsiveness and the inflammatory response after seasonal exposure. Seasonal exposure was related to a more marked systemic inflammatory blood-eosinophil increase than bronchial challenge [(median) (0.25 vs 0.11 x 109/L, P = 0.03)] and after nasal challenge, respectively [(median) (0.25 vs 0.04 x 109/L, P = 0.003)]. A significant correlation in eosinophil cationic protein in induced sputum was found between the experimental and seasonal exposure (rho = 0.62, P = 0.02).
Bronchial allergen challenge with inhalation of birch pollen gives a similar inflammatory response in the airway but less systemic inflammation than seasonal exposure in birch pollen allergic patients with asthma and rhinitis.
季节性过敏是研究过敏性炎症相关病理生理机制的一个有趣模型。然而,实验性过敏原暴露更易于实施且可标准化。本研究的主要目的是比较在桦树花粉季节高剂量支气管激发与自然暴露后的炎症反应。第二个目的是分别比较变应性鼻炎和变应性哮喘患者对两种过敏原暴露的反应。
在花粉季节及用桦树过敏原激发后,对15名桦树花粉过敏患者(7名哮喘患者和8名鼻炎患者)及5名健康个体进行了研究。记录症状、用药情况及呼气峰值流速(PEFR),并在季节期间及激发后分析血样、肺功能及诱导痰。
变应性哮喘患者对桦树过敏原支气管激发的支气管反应性高于鼻炎患者(P = 0.04),而鼻激发方面未发现差异。季节性暴露后反应性水平与炎症反应之间未发现显著关联。与支气管激发相比,季节性暴露与全身炎症性血嗜酸性粒细胞更明显的增加相关[(中位数)(0.25对0.11×10⁹/L,P = 0.03)],在鼻激发后分别为[(中位数)(0.25对0.04×10⁹/L,P = 0.003)]。诱导痰中嗜酸性粒细胞阳离子蛋白在实验性暴露与季节性暴露之间存在显著相关性(rho = 0.62,P = 0.02)。
对于患有哮喘和鼻炎的桦树花粉过敏患者,吸入桦树花粉进行支气管过敏原激发在气道中产生的炎症反应相似,但全身炎症比季节性暴露少。